You are here

Responses

Article menu

Download PDFPDF

Special communication
Global tobacco advertising, promotion and sponsorship regulation: what’s old, what’s new and where to next?
Free
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 29 April 2023
    Addressing Tobacco Control in Psychiatric Settings
    • LienChung Wei, Psychiatrist Department of Counseling and Industrial/Organizational Psychology, Ming Chuan University, Taipei, Taiwan

    NOT PEER REVIEWED
    I read with interest the article "Global tobacco advertising, promotion, and sponsorship regulation: what’s old, what’s new, and where to next?[1]" published in Tobacco Control. As a psychiatrist specializing in addiction treatment at Taoyuan Psychiatric Center in Taiwan, I wish to share our institution's experience in implementing a successful smoke-free hospital program, which may serve as a model for other psychiatric centers.

    Since 2014, Taoyuan Psychiatric Center has made significant progress in promoting a smoke-free environment through a comprehensive tobacco control program. Our program's objectives include creating a smoke-free hospital, increasing smoking cessation services for outpatients and inpatients, and improving patient smoking status documentation. Furthermore, we prioritize smoking cessation counseling for adolescents, pregnant women, and their families.

    In psychiatric settings, smoking cessation is crucial as tobacco use can influence the blood concentration of psychotropic medications, potentially destabilizing psychiatric symptoms. Assisting patients in quitting smoking not only lowers the risk of tobacco-related diseases but also contributes to stabilizing their psychiatric conditions.

    Our program encompasses various initiatives, including staff training, community tobacco harm prevention promotion, provision of second-generation smoking cessation treatments for outpatients and inpatien...

    Show More
    Conflict of Interest:
    None declared.